全文获取类型
收费全文 | 3797篇 |
免费 | 221篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 143篇 |
妇产科学 | 203篇 |
基础医学 | 475篇 |
口腔科学 | 63篇 |
临床医学 | 310篇 |
内科学 | 776篇 |
皮肤病学 | 47篇 |
神经病学 | 542篇 |
特种医学 | 105篇 |
外科学 | 476篇 |
综合类 | 13篇 |
一般理论 | 1篇 |
预防医学 | 188篇 |
眼科学 | 38篇 |
药学 | 302篇 |
中国医学 | 13篇 |
肿瘤学 | 328篇 |
出版年
2023年 | 36篇 |
2022年 | 73篇 |
2021年 | 108篇 |
2020年 | 58篇 |
2019年 | 86篇 |
2018年 | 94篇 |
2017年 | 98篇 |
2016年 | 90篇 |
2015年 | 110篇 |
2014年 | 129篇 |
2013年 | 164篇 |
2012年 | 245篇 |
2011年 | 250篇 |
2010年 | 138篇 |
2009年 | 130篇 |
2008年 | 197篇 |
2007年 | 187篇 |
2006年 | 211篇 |
2005年 | 206篇 |
2004年 | 168篇 |
2003年 | 141篇 |
2002年 | 134篇 |
2001年 | 77篇 |
2000年 | 58篇 |
1999年 | 95篇 |
1998年 | 41篇 |
1997年 | 38篇 |
1996年 | 31篇 |
1995年 | 32篇 |
1994年 | 30篇 |
1993年 | 24篇 |
1992年 | 47篇 |
1991年 | 55篇 |
1990年 | 54篇 |
1989年 | 43篇 |
1988年 | 43篇 |
1987年 | 32篇 |
1986年 | 23篇 |
1985年 | 33篇 |
1984年 | 27篇 |
1983年 | 21篇 |
1982年 | 18篇 |
1981年 | 14篇 |
1979年 | 21篇 |
1978年 | 13篇 |
1977年 | 9篇 |
1974年 | 14篇 |
1973年 | 10篇 |
1969年 | 10篇 |
1966年 | 9篇 |
排序方式: 共有4036条查询结果,搜索用时 15 毫秒
51.
MR imaging findings in spinal ligamentous injury 总被引:2,自引:0,他引:2
52.
The clinical usefulness of total sleep deprivation (TSD) in the treatment of bipolar depression is hampered by a high-rate short-term relapse. Previous literature has suggested that both long-term lithium treatment and light therapy could successfully prevent relapse. We randomized 115 bipolar depressed inpatients to receive three cycles of TSD, alone or in combination with morning light exposure, given at an intensity of 150 or 2500 lux. Forty-nine patients were undergoing long-term treatment with lithium salts (at least 6 months), while 66 patients were taking no psychotropic medication. Mood was self-rated by the Visual Analogue Scale three times a day during treatment. The results showed that both light therapy and ongoing lithium treatment significantly enhanced the effects of TSD on the perceived mood, with no additional benefit when the two treatments were combined. Subjective sleepiness during TSD, as rated by the self-administered Stanford Sleepiness Scale, was significantly reduced by light exposure, and was correlated with the outcome. This study confirms the possibility of obtaining a sustained antidepressant response to TSD in bipolar patients. 相似文献
53.
The experience with living donors for intestinal transplantation is limited. However, Intestinal Registry data suggest that the outcomes of the procedure are comparable with those obtained with intestinal transplant from deceased donors. In selected cases, this strategy may have a role in the treatment of patients with irreversible intestinal failure suffering life-threatening complications from total parenteral nutrition. The present review covers most of the published data on this topic between 2003 and 2006, with special reference to living donor intestinal transplantation of pediatric recipients. 相似文献
54.
Marquis P Vawter Simon Evans Prabhakara Choudary Hiroaki Tomita Jim Meador-Woodruff Margherita Molnar Jun Li Juan F Lopez Rick Myers David Cox Stanley J Watson Huda Akil Edward G Jones William E Bunney 《Neuropsychopharmacology》2004,29(2):373-384
Gender differences in brain development and in the prevalence of neuropsychiatric disorders such as depression have been reported. Gender differences in human brain might be related to patterns of gene expression. Microarray technology is one useful method for investigation of gene expression in brain. We investigated gene expression, cell types, and regional expression patterns of differentially expressed sex chromosome genes in brain. We profiled gene expression in male and female dorsolateral prefrontal cortex, anterior cingulate cortex, and cerebellum using the Affymetrix oligonucleotide microarray platform. Differentially expressed genes between males and females on the Y chromosome (DBY, SMCY, UTY, RPS4Y, and USP9Y) and X chromosome (XIST) were confirmed using real-time PCR measurements. In situ hybridization confirmed the differential expression of gender-specific genes and neuronal expression of XIST, RPS4Y, SMCY, and UTY in three brain regions examined. The XIST gene, which silences gene expression on regions of the X chromosome, is expressed in a subset of neurons. Since a subset of neurons express gender-specific genes, neural subpopulations may exhibit a subtle sexual dimorphism at the level of differences in gene regulation and function. The distinctive pattern of neuronal expression of XIST, RPS4Y, SMCY, and UTY and other sex chromosome genes in neuronal subpopulations may possibly contribute to gender differences in prevalence noted for some neuropsychiatric disorders. Studies of the protein expression of these sex-chromosome-linked genes in brain tissue are required to address the functional consequences of the observed gene expression differences. 相似文献
55.
56.
Majolino I Ladetto M Locasciulli A Drandi D Benedetti F Gallamini A Chisesi T De Blasio A Boccadoro M Tarella C 《Medical oncology (Northwood, London, England)》2006,23(3):359-368
B-CLL patients with resistant/relapsed disease or adverse prognostic factors at presentation are suitable for alternative treatments. In the present pilot study we investigated a novel intensive chemo-immunotherapy approach for high-risk, fludarabine pretreated patients. Ten patients with resistant/relapsed, advanced stage BCLL were included. Age was 37-60 yr (median 53). All but one had an unmutated IgVH status. The treatment schedule included debulking with two DHAP courses followed by alemtuzumab (30 mg, eight doses), followed by peripheral blood progenitor cell (PBPC) mobilization with intermediate/high-dose cyclophosphamide and by autografting after high-dose mitoxantrone+L-Pam. The DHAP-alemtuzumab combination was highly effective. Eight patients out of 10 responded to DHAP, with a single complete remission. Following alemtuzumab, the number of overall responses increased to nine, and the complete remissions to five. After alemtuzumab PB double-positive clonal CD5+/CD19+ lymphocytes dropped, with median purification rate 99.95%. Owing to poor PBPC mobilization, only five patients underwent autografting, and three of these experienced post-graft recurrence. The six patients entering complete remission were free of disease 3-23 mo after study entry, and three of them were still in remission at 3, 7, and 22 mo. However, molecular evaluation regularly revealed persistence of minimal residual disease, both in all PBPC collections tested and in post-treatment follow-up samples. The use of DHAP/alemtuzumab appears useful to re-induce disease remission in relapsed/refractory, high-risk B-CLL patients. However, the addition of autograft was not usually feasible and of questionable clinical use. Other strategies should thus be considered for remission maintenance. 相似文献
57.
Simone Murchio Matteo Benedetti Anastasia Berto Francesca Agostinacchio Gianluca Zappini Devid Maniglio 《Materials》2022,15(17)
Despite the tremendous technological advances that metal additive manufacturing (AM) has made in the last decades, there are still some major concerns guaranteeing its massive industrial application in the biomedical field. Indeed, some main limitations arise in dealing with their biological properties, specifically in terms of osseointegration. Morphological accuracy of sub-unital elements along with the printing resolution are major constraints in the design workspace of a lattice, hindering the possibility of manufacturing structures optimized for proper osteointegration. To overcome these issues, the authors developed a new hybrid multifunctional composite scaffold consisting of an AM Ti6Al4V lattice structure and a silk fibroin/gelatin foam. The composite was realized by combining laser powder bed fusion (L-PBF) of simple cubic lattice structures with foaming techniques. A combined process of foaming and electrodeposition has been also evaluated. The multifunctional scaffolds were characterized to evaluate their pore size, morphology, and distribution as well as their adhesion and behavior at the metal–polymer interface. Pull-out tests in dry and hydrated conditions were employed for the mechanical characterization. Additionally, a cytotoxicity assessment was performed to preliminarily evaluate their potential application in the biomedical field as load-bearing next-generation medical devices. 相似文献
58.
Luisa Carbognin Cristina Accetta Danilo Di Giorgio Paola Fuso Margherita Muratore Giordana Tiberi Francesco Pavese Tatiana DAngelo Alessandra Fabi Diana Giannarelli Alba Di Leone Stefano Magno Giorgia Garganese Alejandro Martin Sanchez Daniela Andreina Terribile Gianluca Franceschini Riccardo Masetti Giovanni Scambia Ida Paris 《Current oncology (Toronto, Ont.)》2022,29(10):7218
The prevention of chemotherapy-induced alopecia still represents an urgent need for every day clinical practice. In this regard, this prospective single-center study included breast cancer (BC) patients who underwent a scalp cooling device (Dignicap®) during (neo)adjuvant chemotherapy with the aim to evaluate the efficacy and safety of this device in preventing alopecia. One hundred and seventy-eight patients (median age 43 years) were enrolled. The chemotherapy regimen included anthracycline and taxane-based chemotherapy (68.1%), docetaxel and cyclophosphamide (25.8%), anthracycline and taxane-based plus carboplatin (3.9%), and paclitaxel alone (2.2%). In 25.3% of cases, a dose dense schedule was used. Overall, the success rate was 68.0%: 100% in paclitaxel alone, 87.0% in docetaxel-cyclophosphamide, 59.5% in anthracycline and taxane, and 71.4% in the sequential regimen plus carboplatin group (anthracycline and taxane-based chemotherapy versus taxane-based chemotherapy, p ≤ 001. No difference in terms of hair preservation between dose-dense or standard schedule was found (p = 0.557). Early discontinuation of the scalp cooling was observed in 50 patients (28.1%). Although 138 patients (77.5%) experienced adverse events, 70.2% of patients were satisfied with this device. In conclusion, this large prospective study confirmed the helpful effect of the scalp cooling system in preventing alopecia in BC patients also undergoing sequential anthracyclines and taxane-based chemotherapy. 相似文献
59.
Federica Medici Stefania Rizzo Milly Buwenge Alessandra Arcelli Martina Ferioli Gabriella Macchia Francesco Deodato Savino Cilla Pierandrea De Iaco Anna Myriam Perrone Silvia Strolin Lidia Strigari Gloria Ravegnini Alberto Bazzocchi Alessio G. Morganti 《Current oncology (Toronto, Ont.)》2022,29(11):8513
Sarcopenia (SP) is a syndrome characterized by age-associated loss of skeletal muscle mass and function. SP worsens both acute and late radiation-induced toxicity, prognosis, and quality of life. Myosteatosis is a pathological infiltration of muscle tissue by adipose tissue which often precedes SP and has a proven correlation with prognosis in cancer patients. Sarcopenic obesity is considered a “hidden form” of SP (due to large fat mass) and is independently related to higher mortality and worse complications after surgery and systemic treatments with worse prognostic impact compared to SP alone. The evaluation of SP is commonly based on CT images at the level of the middle of the third lumbar vertebra. On this scan, all muscle structures are contoured and then the outlined surface area is calculated. Several studies reported a negative impact of SP on overall survival in patients undergoing RT for tumors of the head and neck, esophagus, rectum, pancreas, cervix, and lung. Furthermore, several appetite-reducing side effects of RT, along with more complex radiation-induced mechanisms, can lead to SP through, but not limited to, reduced nutrition. In particular, in pediatric patients, total body irradiation was associated with the onset of SP and other changes in body composition leading to an increased risk of cardiometabolic morbidity in surviving adults. Finally, some preliminary studies showed the possibility of effectively treating SP and preventing the worsening of SP during RT. Future studies should be able to provide information on how to prevent and manage SP before, during, or after RT, in both adult and pediatric patients. 相似文献
60.
Dixon B. Kaufman George W. Burke III David S. Bruce Christopher P. Johnson A. Osama Gaber David E. R. Sutherland Robert M. Merion Scott A. Gruber Eugene Schweitzer John P. Leone Christopher L. Marsh Edward Alfrey Waldo Concepcion Mark D. Stegall James A. Schulak Paul F. Gores Enrico Benedetti Craig Smith Alice K. Henning Fernando Kuehnel Sarah King William E. Fitzsimmons 《American journal of transplantation》2003,3(7):855-864
A randomized, multicenter, prospective study was conducted at 18 pancreas transplant centers in the United States to determine the role of induction therapy in simultaneous pancreas-kidney (SPK) transplantation. One hundred and 74 recipients were enrolled: 87 recipients each in the induction and noninduction treatment arms. Maintenance immunosuppression consisted of tacrolimus, mycophenolate mofetil, and corticosteroids. There were no statistically significant differences between treatment groups for patient, kidney, and pancreas graft survival at 1-year. The 1-year cumulative incidence of any treated biopsy-confirmed or presumptive rejection episodes (kidney or pancreas) in the induction and noninduction treatment arms was 24.6% and 31.2% (p = 0.28), respectively. The 1-year cumulative incidence of biopsy-confirmed, treated, acute kidney allograft rejection in the induction and noninduction treatment arms was 13.1% and 23.0% (p = 0.08), respectively. Biopsy-confirmed kidney allograft rejection occurred later post-transplant and appeared to be less severe among recipients that received induction therapy. The highest rate of Cytomegalovirus (CMV) viremia/syndrome was observed in the subgroup of recipients who received T-cell depleting antibody induction and received organs from CMV serologically positive donors. Decisions regarding the routine use of induction therapy in SPK transplantation must take into consideration its differential effects on risk of rejection and infection. 相似文献